Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Cancer Metastatic × patritumab deruxtecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Breast Cancer Metastatic 1

Interventions

dalpiciclib 2 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 olaparib 1 fluzoparib 1 apatinib 1 Ga(III)-DOTATOC 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06298084 2024-03-29

ICARUSBREAST02

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡